Predicted percentage with AE within 5 years, based on observed baseline characteristics. Crude and standardized to age-sex distribution of TNFi as first bDMARD
| All-cause mortality | All-cause hospitalization | Malignancy | MACE | Serious infection | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Crude | Std | Crude | Std | Crude | Std | Crude | Std | Crude | Std | |
| First bDMARD | ||||||||||
| TNFi | 4.9 | 60.3 | 5.4 | 6.2 | 15.3 | |||||
| Rit. | 12.8 | 6.7 | 74.0 | 67.6 | 7.7 | 5.7 | 11.9 | 7.3 | 25.6 | 18.9 |
| Toc. | 8.5 | 7.7 | 63.6 | 64.2 | 5.8 | 5.2 | 8.4 | 8.8 | 19.4 | 18.8 |
| Aba. | 11.6 | 6.9 | 67.5 | 61.5 | 6.2 | 5.0 | 12.4 | 7.1 | 22.1 | 17.3 |
| Switch from TNFi | ||||||||||
| TNFi | 5.3 | 5.5 | 68.8 | 68.6 | 5.0 | 5.1 | 7.0 | 7.2 | 17.8 | 18.0 |
| Rit. | 7.8 | 6.4 | 74.6 | 71.7 | 5.7 | 4.9 | 9.3 | 7.3 | 22.4 | 20.1 |
| Toc. | 6.5 | 6.8 | 72.3 | 68.3 | 5.3 | 5.0 | 8.4 | 8.0 | 19.8 | 18.8 |
| Aba. | 7.5 | 5.6 | 71.1 | 71.4 | 5.5 | 5.0 | 8.8 | 7.6 | 20.7 | 18.9 |